Ocusoft Homatropine Hydrobromide recalls

The FDA has published 1 recall involving Ocusoft Homatropine Hydrobromide since 2019. The latest was reported on 27 Nov 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 27 Nov 2019

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why ocusoft homatropine hydrobromide is recalled

Sterility1100%

Companies

Altaire Pharmaceuticals1100%

By year

20191100%

All ocusoft homatropine hydrobromide recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
27 Nov 2019Drug	CLASS II	OCuSOFT Homatropine Hydrobromide Ophthalmic Solution recalled	Altaire Pharmaceuticals	Sterility	Nationwide

Should you stop taking Ocusoft Homatropine Hydrobromide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.